Novo Nordisk A S (NVO) EBT Margin (2012 - 2016)
Novo Nordisk A S's (NVO) quarterly EBT Margin came in at 45.86% in Q2 2016, up 697.0% YoY from 5.75% in Q3 2015, and up 4.37% on a QoQ basis from 43.94% in Q1 2016.
Novo Nordisk A S (NVO) EBT Margin (2012 - 2016) Analysis & Trends
Novo Nordisk A S (NVO) has 5 years of EBT Margin data on file, last reported at 45.86% in Q2 2016.
- Quarterly EBT Margin rose 697.0% year-over-year to 45.86% in Q2 2016, while the trailing twelve-month figure through Jun 2016 was 40.79% (up 97.0% YoY) and the FY2019 annual result came in at 145.95%, up 465.0% from the prior year.
- EBT Margin advanced to 45.86% in Q2 2016, from 43.94% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 49.53% in Q1 2015 to a low of 33.62% in Q4 2014.
- A 5-year average of 39.11% and a median of 38.4% in 2013 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2015 — EBT Margin soared 871 bps — and 2016, when it tumbled 559 bps.
- Tracing NVO's EBT Margin over 5 years: stood at 35.57% in 2012, then gained by 1 bps to 36.0% in 2013, then retreated by 7 bps to 33.62% in 2014, then advanced by 6 bps to 35.64% in 2015, then climbed by 29 bps to 45.86% in 2016.
- The last three EBT Margin figures came in at 45.86% (Q2 2016), 43.94% (Q1 2016), and 35.64% (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 45.86% |
| Mar 31, 2016 | 43.94% |
| Dec 31, 2015 | 35.64% |
| Sep 30, 2015 | 37.81% |
| Jun 30, 2015 | 38.89% |
| Mar 31, 2015 | 49.53% |
| Dec 31, 2014 | 33.62% |
| Sep 30, 2014 | 37.93% |
| Jun 30, 2014 | 41.56% |
| Mar 31, 2014 | 40.81% |
| Dec 31, 2013 | 36.00% |
| Sep 30, 2013 | 40.43% |
| Jun 30, 2013 | 40.62% |
| Mar 31, 2013 | 38.87% |
| Dec 31, 2012 | 35.57% |
| Sep 30, 2012 | 37.13% |
| Jun 30, 2012 | 35.66% |
| Mar 31, 2012 | 34.13% |